174 related articles for article (PubMed ID: 2439347)
1. Detection of HLA-DP serological allodeterminants by the use of radioiodinated DP molecules.
Tanigaki N; Tosi R; Parodi B; Sorrentino R; Ferrara GB; Strominger JL
Eur J Immunol; 1987 Jun; 17(6):743-50. PubMed ID: 2439347
[TBL] [Abstract][Full Text] [Related]
2. Serological detection and molecular localization of allelic HLA-DP supertypic epitopes.
Colonna M; Tanigaki N; Tosi R; Ferrara GB
Eur J Immunol; 1989 Mar; 19(3):433-40. PubMed ID: 2468502
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
4. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
Pesando JM; Graf L
J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
[TBL] [Abstract][Full Text] [Related]
6. HLA-D region alpha-chain monoclonal antibodies: cross-reaction between an anti-DP alpha-chain antibody and smooth muscle.
Thomas A; Lindsay J; Wilkinson M; Bodmer J
J Pathol; 1988 Apr; 154(4):353-63. PubMed ID: 2455029
[TBL] [Abstract][Full Text] [Related]
7. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
8. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules.
Klohe EP; Watts R; Bahl M; Alber C; Yu WY; Anderson R; Silver J; Gregersen PK; Karr RW
J Immunol; 1988 Sep; 141(6):2158-64. PubMed ID: 2459201
[TBL] [Abstract][Full Text] [Related]
10. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.
Ulvestad E; Williams K; Bø L; Trapp B; Antel J; Mørk S
Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916
[TBL] [Abstract][Full Text] [Related]
11. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
12. Differential MHC class II expression on human peripheral blood monocytes and dendritic cells.
Brooks CF; Moore M
Immunology; 1988 Feb; 63(2):303-11. PubMed ID: 3350576
[TBL] [Abstract][Full Text] [Related]
13. Epitopes of HLA-A, B, C, DR, DQ, DP and MICA antigens.
El-Awar N; Terasaki PI; Cai J; Deng CT; Ozawa M; Nguyen A; Lias M; Conger N
Clin Transpl; 2009; ():295-321. PubMed ID: 20524293
[TBL] [Abstract][Full Text] [Related]
14. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
Diedrichs M; Schendel DJ
J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
[TBL] [Abstract][Full Text] [Related]
15. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a monoclonal antibody recognizing a monomorphic determinant of DR antigens.
Schütt C; Horejsi V; Walzel H; Siegl E
Biomed Biochim Acta; 1989; 48(4):359-63. PubMed ID: 2473743
[TBL] [Abstract][Full Text] [Related]
17. HLA-DP can be expressed with or without -DR molecules on a malignant B cell line.
Pesando JM; Graf L; Hoffman P
J Immunol; 1986 Sep; 137(6):1932-6. PubMed ID: 3489045
[TBL] [Abstract][Full Text] [Related]
18. Influence of HLA-DP mismatches on primary MLR responses in unrelated HLA-A, B, DR, DQ, Dw identical pairs in allogeneic bone marrow transplantation.
Cesbron A; Moreau P; Milpied N; Muller JY; Harousseau JL; Bignon JD
Bone Marrow Transplant; 1990 Nov; 6(5):337-40. PubMed ID: 1981326
[TBL] [Abstract][Full Text] [Related]
19. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
[TBL] [Abstract][Full Text] [Related]
20. Activated T cells and monocytes have characteristic patterns of class II antigen expression.
Robbins PA; Maino VC; Warner NL; Brodsky FM
J Immunol; 1988 Aug; 141(4):1281-7. PubMed ID: 3135327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
